PATH EX is developing CycloPE®, a medical device intended to rapidly eradicate bacteria from the bloodstream in patients suffering from sepsis. The company is led by CEO Sinead Miller and is based in Houston, TX. PATH EX recently raised $5M to support its program. The financing is intended to accelerate development and future commercialization of CycloPE®. In parallel with the financing the company added Jeff Burbank to its Board of Directors. Investors in the round include IAG Capital Partners, TMC Venture Fund and Fitz Gate Ventures.

Total raised

$5M

Funding rounds

1

Latest round

Equity

Latest activity

May 2025